title: Risk assessment of drug-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a disproportionality analysis using the French Pharmacovigilance Database.
authors.affiliation: Department of Clinical Pharmacology, Regional Pharmacovigilance Center, CHRU Tours, 37044, Tours CEDEX 9, France.
authors.forename: M S
authors.initials: MS
authors.lastname: Agier
authors.affiliation: Department of Clinical Pharmacology, Regional Pharmacovigilance Center, CHRU Tours, 37044, Tours CEDEX 9, France.
authors.forename: N
authors.initials: N
authors.lastname: Boivin
authors.affiliation: Department of Dermatology, CHRU Tours, 37044, Tours CEDEX 9, France.|University François Rabelais Tours, 37000, Tours, France.|INSERM U930, 37044, Tours CEDEX 9, France.
authors.forename: A
authors.initials: A
authors.lastname: Maruani
authors.affiliation: University François Rabelais Tours, 37000, Tours, France.|Clinical Investigation Center - INSERM 1415, 37044, Tours CEDEX 9, France.
authors.forename: B
authors.initials: B
authors.lastname: Giraudeau
authors.affiliation: Regional Pharmacovigilance Center, Hospices Civils de Lyon, 69424, Lyon, France.
authors.forename: A
authors.initials: A
authors.lastname: Gouraud
authors.affiliation: Department of Clinical Pharmacology, Regional Pharmacovigilance Center, Hôpital Pellegrin, 33076, Bordeaux, France.
authors.forename: F
authors.initials: F
authors.lastname: Haramburu
authors.affiliation: Regional Pharmacovigilance Center, Hôpital Salvator, Assistance Publique Hôpitaux de Marseille, 13274, Marseille, France.
authors.forename: M J
authors.initials: MJ
authors.lastname: Jean Pastor
authors.affiliation: Department of Dermatology, CHRU Tours, 37044, Tours CEDEX 9, France.|University François Rabelais Tours, 37000, Tours, France.|INSERM U930, 37044, Tours CEDEX 9, France.
authors.forename: L
authors.initials: L
authors.lastname: Machet
authors.affiliation: Department of Clinical Pharmacology, Regional Pharmacovigilance Center, CHRU Tours, 37044, Tours CEDEX 9, France. jonville-bera@chu-tours.fr.
authors.forename: A P
authors.initials: AP
authors.lastname: Jonville-Bera
mesh_terms: D000328:Adult; D000368:Aged; D000493:Allopurinol / Q000009:adverse effects; D000890:Anti-Infective Agents / Q000009:adverse effects; D000925:Anticoagulants / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D063926:Drug Hypersensitivity Syndrome / Q000453:epidemiology*; D005260:Female; D005602:France / Q000453:epidemiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D060735:Pharmacovigilance; D010630:Phenindione / Q000009:adverse effects / Q000031:analogs & derivatives; D018570:Risk Assessment / Q000379:methods
chemical_list: D000890:Anti-Infective Agents; D000925:Anticoagulants; D000927:Anticonvulsants; D010630:Phenindione; D000493:Allopurinol; C017673:fluindione